Non-apoptotic Fas signaling
- PMID: 12485619
- DOI: 10.1016/s1359-6101(02)00072-2
Non-apoptotic Fas signaling
Abstract
Fas (Apo-1, CD95) and Fas-Ligand (FasL, CD95L) are typical members of the TNF receptor and TNF ligand family, respectively, with a pivotal role in the regulation of apoptotic processes, including activation-induced cell death, T-cell-induced cytotoxicity, immune privilege and tumor surveillance. Impairment of the FasL/Fas system has been implicated in liver failure, autoimmune diseases and immune deficiency. Thus, the FasL/Fas system was mainly appreciated with respect to its death-inducing capabilities. However, there is increasing evidence that activation of Fas can also result in non-apoptotic responses like cell proliferation or NF-kappaB activation. While the apoptotic features of the FasL/Fas system and the pathways involved are comparably well investigated, the pathways that are utilized by Fas to transduce proliferative and activating signals are poorly understood. This review is focused on the non-apoptotic functions of the FasL/Fas system. In particular, the similarities and differences of the molecular mechanisms of apoptotic and non-apoptotic Fas signaling are addressed.
Similar articles
-
Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.J Immunol. 2005 Dec 1;175(11):7244-54. doi: 10.4049/jimmunol.175.11.7244. J Immunol. 2005. PMID: 16301629
-
Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages.Am J Physiol Cell Physiol. 2002 Sep;283(3):C831-8. doi: 10.1152/ajpcell.00045.2002. Am J Physiol Cell Physiol. 2002. PMID: 12176740
-
The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.Curr Biol. 2000 Jun 1;10(11):640-8. doi: 10.1016/s0960-9822(00)00512-1. Curr Biol. 2000. PMID: 10837247
-
Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas.Int Rev Cytol. 2002;214:225-72. doi: 10.1016/s0074-7696(02)14007-1. Int Rev Cytol. 2002. PMID: 11893167 Review.
-
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways.Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):189004. doi: 10.1016/j.bbcan.2023.189004. Epub 2023 Oct 20. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37865305 Review.
Cited by
-
Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.Tumour Biol. 2015 May;36(5):3159-69. doi: 10.1007/s13277-015-3363-9. Epub 2015 Apr 1. Tumour Biol. 2015. PMID: 25828146 Review.
-
Prolonged exposure of naïve CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length.Immunology. 2006 Oct;119(2):243-53. doi: 10.1111/j.1365-2567.2006.02429.x. Immunology. 2006. PMID: 17005004 Free PMC article.
-
Up-regulation of Fas (CD95) expression in tumour cells in vivo.Immunology. 2007 Apr;120(4):502-11. doi: 10.1111/j.1365-2567.2006.02521.x. Immunology. 2007. PMID: 17343612 Free PMC article.
-
Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis.Am J Pathol. 2010 Feb;176(2):687-98. doi: 10.2353/ajpath.2010.090222. Epub 2009 Dec 24. Am J Pathol. 2010. PMID: 20035047 Free PMC article.
-
NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.J Cell Biol. 2004 Aug 2;166(3):369-80. doi: 10.1083/jcb.200401036. J Cell Biol. 2004. PMID: 15289496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous